
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1072 | 1038 | 1099 | 1214 | 1562 | 1739 |
Fund Return | 7.22% | 3.85% | 9.9% | 6.69% | 9.33% | 5.69% |
Place in category | 283 | 381 | 290 | 133 | 128 | 95 |
% in Category | 35 | 48 | 41 | 23 | 20 | 25 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
DFA US Core Equity 1 I | 33.44B | 1.39 | 11.27 | 11.79 | ||
DFA US Core Equity 2 I | 31.41B | 1.32 | 10.85 | 11.23 | ||
DFA International Core Equity I | 32.41B | 6.16 | 5.65 | 5.79 | ||
DFA Emerging Markets Core Equity I | 27.68B | -0.04 | 2.01 | 4.45 | ||
DFA US Large Cap Value I | 23.56B | 4.87 | 8.28 | 8.92 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Total Intl Stock Index Inv | 209.79B | 5.17 | 4.34 | 4.95 | ||
Vanguard Total Intl Stock Index Adm | 76.18B | 5.24 | 4.42 | 5.02 | ||
Fidelity International Index Inst | 55.99B | 8.06 | 6.85 | 5.50 | ||
Fidelity Series Global ex US Index | 52.88B | 6.06 | 4.88 | 4.92 | ||
Strategic Advisers International I | 47.55B | 7.61 | 6.47 | 6.11 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 1.26 | 530.2 | +0.99% | |
Roche Holding Participation | CH0012032048 | 1.22 | 305.80 | +0.89% | |
Shell ADR | US7802593050 | 1.15 | 68.77 | +1.52% | |
Louis Vuitton | FR0000121014 | 1.01 | 605.10 | +0.02% | |
RBC | CA7800871021 | 0.98 | 111.49 | +2.46% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review